SEC Form 4 · accession 0001144204-15-034060
Celator Pharmaceuticals Inc · CPXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lawrence David Mayer
Officer — See Remarks
Period of report
May 14, 2015
Accepted (ET)
May 28, 2015 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001327467
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 14, 2015 | M | 55,000 | $2.25 | A | 71,594 | D | |
| Common Stock | holding | — | — | — | 7,468 | I | By spouse | |
| Common Stock | holding | — | — | — | 3,631 | I | By spouse's trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option, Right to BuyF1 | $2.25 | May 14, 2015 | M | 55,000 | D | — | May 24, 2015 | Common Stock | 55,000 | 7,829 | D |
Explanation of responses
- F1The option was fully exercisable. Options to purchase 7,829 shares expired on 5/24/15.
Remarks
President and Chief Scientific Officer